1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Induced Constipation (OIC) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Opioid Induced Constipation (OIC) Drugs Market
1.8.1 Global Opioid Induced Constipation (OIC) Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Opioid Induced Constipation (OIC) Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Opioid Induced Constipation (OIC) Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Opioid Induced Constipation (OIC) Drugs Sales Volume
3.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Opioid Induced Constipation (OIC) Drugs Sales Volume
3.4.1 East Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.5.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.6.1 South Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.8.1 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.9.1 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.10.1 Oceania Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.11.1 South America Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Opioid Induced Constipation (OIC) Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Opioid Induced Constipation (OIC) Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Opioid Induced Constipation (OIC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Opioid Induced Constipation (OIC) Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Opioid Induced Constipation (OIC) Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Opioid Induced Constipation (OIC) Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Opioid Induced Constipation (OIC) Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Opioid Induced Constipation (OIC) Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Opioid Induced Constipation (OIC) Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Opioid Induced Constipation (OIC) Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Opioid Induced Constipation (OIC) Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Opioid Induced Constipation (OIC) Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by Application (2015-2020)
15.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drugs Business
16.1 Ironwood Pharmaceuticals Inc
16.1.1 Ironwood Pharmaceuticals Inc Company Profile
16.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Specification
16.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Purdue Pharma
16.2.1 Purdue Pharma Company Profile
16.2.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Specification
16.2.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Progenics Pharmaceuticals Inc
16.3.1 Progenics Pharmaceuticals Inc Company Profile
16.3.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Specification
16.3.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Daiichi Sankyo Co Ltd
16.4.1 Daiichi Sankyo Co Ltd Company Profile
16.4.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Specification
16.4.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Nektar Therapeutics
16.5.1 Nektar Therapeutics Company Profile
16.5.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Specification
16.5.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Pfizer
16.6.1 Pfizer Company Profile
16.6.2 Pfizer Opioid Induced Constipation (OIC) Drugs Product Specification
16.6.3 Pfizer Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Mundipharma International Limited
16.7.1 Mundipharma International Limited Company Profile
16.7.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Specification
16.7.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Allergan Plc
16.8.1 Allergan Plc Company Profile
16.8.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Specification
16.8.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Shionogi & Co., Ltd
16.9.1 Shionogi & Co., Ltd Company Profile
16.9.2 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Specification
16.9.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 S.L.A. Pharma AG
16.10.1 S.L.A. Pharma AG Company Profile
16.10.2 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Specification
16.10.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Cosmo Pharmaceuticals SA
16.11.1 Cosmo Pharmaceuticals SA Company Profile
16.11.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Specification
16.11.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Sucampo Pharmaceuticals
16.12.1 Sucampo Pharmaceuticals Company Profile
16.12.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Specification
16.12.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Ono Pharmaceutical Co., Ltd
16.13.1 Ono Pharmaceutical Co., Ltd Company Profile
16.13.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Specification
16.13.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Daewoong Pharmaceutical
16.14.1 Daewoong Pharmaceutical Company Profile
16.14.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Specification
16.14.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Bausch Health
16.15.1 Bausch Health Company Profile
16.15.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Specification
16.15.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Takeda Pharmaceutical Company Limited
16.16.1 Takeda Pharmaceutical Company Limited Company Profile
16.16.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Specification
16.16.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 C.B. Fleet Company
16.17.1 C.B. Fleet Company Company Profile
16.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Specification
16.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Theravance Biopharma Inc
16.18.1 Theravance Biopharma Inc Company Profile
16.18.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Specification
16.18.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
17.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
17.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Opioid Induced Constipation (OIC) Drugs Distributors List
18.3 Opioid Induced Constipation (OIC) Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Opioid Induced Constipation (OIC) Drugs (2021-2026)
20.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs (2021-2026)
20.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drugs (2015-2026)
20.4 Global Forecasted Production of Opioid Induced Constipation (OIC) Drugs by Region (2021-2026)
20.4.1 North America Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.2 East Asia Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.3 Europe Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Countriy
21.4 South Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.6 Middle East Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.7 Africa Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.8 Oceania Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.9 South America Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
21.10 Rest of the world Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer